RESUMEN
BACKGROUND: Healthcare workers are a high-risk population for SARS-CoV2 infection. For capacity planning of healthcare providers and to optimize protection of healthcare workers (HCW) in SARS-CoV2 pandemics, it is essential to know the risk of infection and potential immunity status of staff dealing with COVID-19 patients. MATERIALS AND METHODS: We examined seropravalence of SARS-CoV2 IgM/IgG antibodies (AB) in HCW of a region with the highest rate of infection (1570/100,000) during COVID-19 pandemic in Germany, 4 months after its start. Employees of a nonmedical company (MU) served as control group. Demographic data, medical history and working situation were recorded. RESULTS: A total of 1838 HCW and 986 MU volunteered to participate. Seroprevalence for SARS-CoV2 in HCW was 15.1% and 3.7% in MU. Among HCWs, nurses had a seropositivity of 20.0%, ICU personnel 20.3%, housekeepers 19.3%, physicians 12.0%, medical services (e.g., radiology, physiotherapy) 11.3%, administration 7.1% and technical services 6%. Symptoms typical for COVID-19 were not experienced by 10% of seropositive HCWs. CONCLUSION: Seroprevalence of SARS-CoV2 antibodies in HCW of a region heavily affected by COVID-19 is with 15.1% significantly higher than in a control group of nonmedical staff with 3.7%. Infection rate in HCW was higher in staff with close contact to infected patients. Seropositivity in ICU personnel is higher than in other clinical professions. The occupational risk for housekeepers seems to be underestimated.
Asunto(s)
COVID-19 , SARS-CoV-2 , Alemania , Humanos , Unidades de Cuidados Intensivos , Pandemias , Estudios SeroepidemiológicosRESUMEN
OBJECTIVE: This is a retrospective analysis of interventional embolisation performed with catheter angiography in 29 patients with upper gastrointestinal bleeding in the setting of a secondary care hospital. PATIENTS, MATERIALS, AND METHODS: From April 2007 to February 2013, 29 patients with upper gastrointestinal bleeding underwent endovascular diagnostics and treatment. The diagnosis was established by endoscopy, computed tomography or clinically based on a significant decrease in hemoglobin. Transcatheter arterial embolisation was performed with coils, liquid embolic agents, and particles. The technical and clinical outcomes were assessed by postinterventional endoscopy, hemoglobin concentrations, number of necessary transfusions, or surgical interventions, as well as by post-interventional mortality within 28 days after the procedure. RESULTS: Selective angiographic embolisation in upper gastrointestinal bleeding was primarily successful technically and clinically in 22 of 29 patients. In 4/29 cases an angiographic reintervention was performed, which was successful in 3 cases. In 3 cases of primarily technically unsuccessful procedures reintervention was not attempted. No catheterisation-related complications were recorded. Peri-interventional mortality was 31%, but only 2 of these patients died due to uncontrolled massive bleeding, whereas the lethal outcome in the other 7 patients was due to their underlying diseases. CONCLUSION: Transcatheter arterial embolisation is an effective and rapid method in the management of upper gastrointestinal bleeding. Radiological endovascular interventions may considerably contribute to reduced mortality in GI bleeding by avoiding a potential surgical procedure following unsuccessful endoscopic treatment. The study underlines the importance of the combination of interventional endoscopy with interventional radiology in secondary care hospitals for patient outcome in complex and complicated upper gastrointestinal bleeding situations.
Asunto(s)
Cateterismo Periférico/métodos , Embolización Terapéutica/métodos , Hemorragia Gastrointestinal/diagnóstico por imagen , Hemorragia Gastrointestinal/terapia , Radiografía Intervencional/métodos , Tracto Gastrointestinal Superior/diagnóstico por imagen , Adulto , Anciano , Anciano de 80 o más Años , Angiografía/métodos , Femenino , Hemostáticos/uso terapéutico , Humanos , Masculino , Persona de Mediana Edad , Estudios Retrospectivos , Tasa de Supervivencia , Resultado del TratamientoRESUMEN
Intrapancreatic accessory spleen is a rare cause of pancreatic pseudotumors and is located in the pancreatic tail in approximately 1% to 2%. Accessory spleen itself is found in approximately 7% to 15% of the population. Our findings show a case of an intrapancreatic accessory spleen suspected for a malignancy in the pancreatic tail. A 63-year-old man admitted for cholecystitis was incidentally diagnosed with a tumor at the pancreatic tail. On hyperintense magnetic resonance imaging, a solid mass of 1.5 cm in diameter in the pancreatic tail was seen, which contrasted as hyperdense in T2-weighted imaging. Because of inhomogeneous enhancement on the early vascular phase, the diagnosis of a endocrine pancreatic tail carcinoma was suspected. Intraoperatively, an accessory spleen was found in the pancreatic tail. An oncologic left pancreatectomy was performed because of a malignant tumor. Histology showed an intrapancreatic accessory spleen in the pancreatic tail that excluded the presence of cancer. In conclusion, intrapancreatic accessory spleen is a rare cause of unnecessary laparotomy, but the absence of reliable diagnostics for this entity make histologic ascertainment of a benign tumor indispensable. Therefore, we still needed an oncologic tumor resection.
Asunto(s)
Coristoma/diagnóstico , Enfermedades Pancreáticas/diagnóstico , Bazo , Dolor Abdominal/etiología , Colelitiasis/cirugía , Coristoma/cirugía , Diagnóstico Diferencial , Humanos , Imagen por Resonancia Magnética , Masculino , Persona de Mediana Edad , Enfermedades Pancreáticas/cirugía , Neoplasias Pancreáticas/diagnóstico , Tomografía Computarizada por Rayos XRESUMEN
OBJECTIVES: To evaluate technical success rate and clinical outcome of patients with acute embolic superior mesenteric artery (SMA) occlusion who were treated with primary percutaneous revascularization. METHODS: At three medical centers the radiological information system databases were used to identify all patients in whom primary percutaneous revascularization for the treatment of acute embolic SMA occlusion was attempted between 2001 and 2010. Percutaneous treatment was performed in 15 patients (median age 80 years, range 49-88 years). These patients represent the study population. Eleven patients reported abdominal pain. Five patients exhibited peritoneal signs. Revascularization was defined as complete technical success if (1) patency of the SMA with residual stenosis of not more than 30% in diameter and (2) sufficient perfusion of the entire bowel were obtained. RESULTS: Complete technical success was achieved in eleven patients. After percutaneous revascularization laparotomy was performed in six patients and in three of them bowel resection was carried out (length of resected segments 20-80 cm). The 30-day mortality was 33% (five of 15 patients). None of the surviving patients exhibited short-bowel syndrome. CONCLUSIONS: Primary percutaneous aspiration and thrombolysis constitutes a promising alternative to surgical revascularization in selected patients with acute embolic SMA occlusion.
Asunto(s)
Embolia Aérea/terapia , Oclusión Vascular Mesentérica/terapia , Succión/métodos , Terapia Trombolítica/métodos , Anciano , Anciano de 80 o más Años , Embolia Aérea/complicaciones , Embolia Aérea/diagnóstico por imagen , Femenino , Humanos , Masculino , Arteria Mesentérica Superior , Oclusión Vascular Mesentérica/diagnóstico por imagen , Oclusión Vascular Mesentérica/etiología , Persona de Mediana Edad , Radiografía , Resultado del TratamientoRESUMEN
BACKGROUND: Intrapancreatic accessory spleen is a rare cause of pancreatic pseudotumors and in about 1-2% located in the pancreatic tail. Accessory spleens itself are found in about 10-15% of the population. Our findings show a case of an intrapancreatic accessory spleen suspected for a malignancy in the pancreatic tail. PATIENT: A 63-year-old man admitted for Cholezystitis was incidencially diagnosed with a tumor at the pancreatic tail. On MRI a hyperintense solid mass of 1.5 cm in diameter in the pancreatic tail was seen, which contrasted hyperdense in T2-weighted imaging. Due to inhomogenous enhancement on the early vascular phase the diagnosis of a endocrine pancreatic tail Carcinoma was suspected. RESULTS: Intraoperative an accessory spleen was found in the pancreatic tail. An oncological left pancreatectomy was performed suspecting a malignant tumor. Histology showed an intrapancreatic accessory spleen in the pancreatic tail excluding presence of cancer. CONCLUSION: Intrapancreatic accessory spleen is a rare cause of unnecessary laparotomy but the absence of reliable diagnostics for this entity make histological ascertainment of a benign tumor indispensable. Therefore we still need an oncological tumor resection.
Asunto(s)
Coristoma/diagnóstico , Enfermedades Pancreáticas/diagnóstico , Bazo , Humanos , Masculino , Persona de Mediana EdadRESUMEN
AIMS: Neurinoma of the recurrent nerve presented a rare diagnosis in thyroid gland surgery. METHODS: A case report is presented and the result of the neurinoma of the recurrent nerve extirpation--nerve paresis--is discussed with the rare results in literature. RESULTS: The preoperative diagnosis is difficult and intraoperative histological diagnosis was not correct. The postoperative paresis of the nerve was clinical only very light. CONCLUSION: The problematical neuromonitoring by isolated nodes in parathyroideal regions and after their exstirpation must lead to the suspicion of a recurrent nerve neurinoma.
Asunto(s)
Neoplasias de los Nervios Craneales/cirugía , Neurilemoma/cirugía , Nervio Laríngeo Recurrente , Adulto , Neoplasias de los Nervios Craneales/complicaciones , Neoplasias de los Nervios Craneales/diagnóstico , Humanos , Hallazgos Incidentales , Neurilemoma/complicaciones , Neurilemoma/diagnóstico , Complicaciones Posoperatorias , Parálisis de los Pliegues Vocales/etiologíaRESUMEN
PURPOSE: The organ shortage has led to increasing acceptance of living donation in all transplant centers. Although the risk of impaired long-term outcome seems to be greater using elderly donors, these organs are not generally refused for transplantation. We report our experience with 25 living donor kidney transplantations from donors older than 60 years. METHODS: Between 1995 and 2004, 124 living donor procedures were performed in our center from 83 related and 41 unrelated donors. Twenty-five donors (19 female, 6 male) were 60 years or older (mean, 65.3 +/- 3.9 years). The recipient included (10 females and 15 males) showed a higher degree of variance in age (46.1 +/- 14.6 years). The immunosuppressive protocol was cyclosporine (CyA)-based regimen in related cases and tacrolimus-based in unrelated cases. RESULTS: We transplanted 16 left and 9 right kidneys from older donors. The mean cold ischemia time was 171 +/- 64 minutes with a second warm ischemia time of 24 +/- 6 minutes. Severe arteriosclerosis made vascular reconstruction by graft interposition necessary in two recipients. The acute rejection rate was 20%. Two patients (8%) required dialysis in the early postoperative course, whereas initial function was excellent in 22 patients (88%). The mean serum creatinine concentration after 12 months was 1.6 +/- 0.3 mg/dL (n = 24) and 2.0 +/- 0.7 mg/dL (n = 16) at 4 years. In comparison, the mean creatinine concentration after 4 years in donors under 60 years was 1.6 +/- 0.9 mg/dL. Our analysis showed no significant difference in long-term graft function comparing young versus old donors in the setting of living donor transplants. CONCLUSION: Using living donors older than 60 years for transplantation is a feasible and safe option. The difference in long-term creatinine between young and old donors was not significant.
Asunto(s)
Riñón , Donadores Vivos , Factores de Edad , Anciano , Femenino , Humanos , Donadores Vivos/provisión & distribución , Masculino , Persona de Mediana Edad , Estudios RetrospectivosRESUMEN
AIMS/HYPOTHESIS: Symptoms of gastroparesis possess a heavy impact on the quality of life; delayed gastric emptying may result in poor metabolic control in diabetics. Gastric electrical stimulation (GES) has recently been introduced as a treatment option in patients with drug refractory gastroparesis to increase the quality of life by alleviating nausea and vomiting frequencies. However, the effect of GES on metabolic control has not been assessed yet. METHODS: We performed a prospective single center study on the long-term effect (12 months) of continuous high-frequency/low-energy GES on symptoms, gastric emptying (measured scintigraphically), and metabolic control (HbA1c) in insulin-dependent diabetic subjects suffering from drug-refractory gastroparesis for more than one year. RESULTS: Seventeen (12 female, 5 male) patients entered the study; all were available for analysis at all time points. No therapy-associated adverse events occurred. Weekly vomiting and nausea frequencies decreased significantly at 6 and 12 months. Gastric retention rates improved significantly from 83 % (2 h) and 38 % (4 h) to 35 % (2 h)/14 % (4 h) and 25 % (2 h)/17 % (4 h) at 6 and 12 months, respectively. HbA1c values were lowered in all 17 subjects; initially, all HbA1c values were above 7.5 %; at 6 and 12 months, mean values had significantly decreased from 8.6 % to 6.2 % and 6.5 %, respectively. CONCLUSIONS/INTERPRETATION: Gastric electrical stimulation offers symptom control in diabetics with drug-refractory gastroparesis and decreases gastric retention. This study, for the first time, documents a positive effect of this therapy on metabolic control as indicated by HbA1c, a surrogate marker of the risk of diabetic complications.
Asunto(s)
Diabetes Mellitus Tipo 1/complicaciones , Terapia por Estimulación Eléctrica , Gastroparesia/fisiopatología , Gastroparesia/terapia , Estómago/fisiopatología , Adulto , Anciano , Femenino , Vaciamiento Gástrico , Gastroparesia/etiología , Hemoglobina Glucada/metabolismo , Humanos , Incidencia , Masculino , Persona de Mediana Edad , Náusea/epidemiología , Náusea/etiología , Vómitos/epidemiología , Vómitos/etiologíaAsunto(s)
Supervivencia de Injerto/fisiología , Trasplante de Riñón/estadística & datos numéricos , Donantes de Tejidos/provisión & distribución , Humanos , Terapia de Inmunosupresión/métodos , Trasplante de Riñón/inmunología , Estudios Retrospectivos , Factores de Tiempo , Donantes de Tejidos/estadística & datos numéricos , Insuficiencia del Tratamiento , Resultado del TratamientoAsunto(s)
Interleucina-10/sangre , Interleucina-6/sangre , Interleucina-8/sangre , Trasplante de Riñón/inmunología , Adulto , Femenino , Rechazo de Injerto/tratamiento farmacológico , Rechazo de Injerto/epidemiología , Humanos , Inmunosupresores/uso terapéutico , Masculino , Monitorización Inmunológica , Complicaciones Posoperatorias/clasificación , Complicaciones Posoperatorias/epidemiología , Valores de Referencia , Análisis de Regresión , Estudios Retrospectivos , Resultado del TratamientoAsunto(s)
Supervivencia de Injerto/fisiología , Trasplante de Riñón/fisiología , Riñón , Donadores Vivos , Quimioterapia Combinada , Femenino , Humanos , Inmunosupresores/uso terapéutico , Trasplante de Riñón/inmunología , Donadores Vivos/estadística & datos numéricos , Masculino , Nefrectomía/métodos , Núcleo Familiar , Preservación de Órganos/métodos , Complicaciones Posoperatorias/clasificación , Complicaciones Posoperatorias/epidemiología , Estudios Retrospectivos , Infección de la Herida Quirúrgica/epidemiología , Factores de Tiempo , Recolección de Tejidos y Órganos/métodos , Resultado del TratamientoAsunto(s)
Supervivencia de Injerto/fisiología , Síndrome Hepatorrenal/cirugía , Fallo Renal Crónico/cirugía , Trasplante de Riñón , Fallo Hepático/cirugía , Trasplante de Hígado , Femenino , Estudios de Seguimiento , Humanos , Fallo Renal Crónico/complicaciones , Trasplante de Riñón/métodos , Fallo Hepático/complicaciones , Trasplante de Hígado/métodos , Masculino , Estudios Retrospectivos , Factores de Tiempo , Resultado del TratamientoAsunto(s)
Infecciones por Clostridium/diagnóstico , Infecciones por Clostridium/tratamiento farmacológico , Clostridium/aislamiento & purificación , Trasplante de Hígado/fisiología , Complicaciones Posoperatorias/prevención & control , Anciano , Resultado Fatal , Femenino , Humanos , Trasplante de Hígado/mortalidad , Masculino , Persona de Mediana Edad , Complicaciones Posoperatorias/mortalidadAsunto(s)
Ciclosporina/uso terapéutico , Trasplante de Hígado/inmunología , Tacrolimus/uso terapéutico , Administración Oral , Adulto , Anciano , Bilirrubina/sangre , Biopsia , Ciclosporina/administración & dosificación , Emulsiones , Femenino , Alemania , Rechazo de Injerto/epidemiología , Rechazo de Injerto/patología , Humanos , Trasplante de Hígado/mortalidad , Trasplante de Hígado/fisiología , Masculino , Persona de Mediana Edad , Reproducibilidad de los Resultados , Análisis de Supervivencia , Tacrolimus/administración & dosificaciónAsunto(s)
Ciclosporina/uso terapéutico , Trasplante de Riñón/inmunología , Tacrolimus/uso terapéutico , Ciclosporina/administración & dosificación , Ciclosporina/farmacocinética , Diltiazem/uso terapéutico , Relación Dosis-Respuesta a Droga , Quimioterapia Combinada , Emulsiones , Europa (Continente) , Femenino , Humanos , Trasplante de Riñón/mortalidad , Masculino , Persona de Mediana Edad , Complicaciones Posoperatorias/clasificación , Complicaciones Posoperatorias/epidemiología , Análisis de Supervivencia , Tacrolimus/administración & dosificaciónRESUMEN
BACKGROUND: In bile duct strictures, examination of wall layers by intraductal ultrasonography (IDUS) performed during endoscopic retrograde cholangiopancreatography (ERCP) may be diagnostically useful. METHODS: In the present study 60 patients with bile duct strictures of unknown aetiology were examined preoperatively by ERCP, including transpapillary biopsies and IDUS. Histopathological correlation was available for all patients undergoing these procedures. RESULTS: Postoperative diagnosis revealed 30 pancreatic carcinomas, 17 bile duct cancers, three gall bladder cancers, and 10 benign bile duct strictures. Using endoscopic transpapillary forceps biopsies (ETP), a correct preoperative diagnosis was achieved in 36 of 60 patients (60% of cases). Among the 50 malignant tumours, preoperative diagnosis by ETP revealed a sensitivity of 52% and a specificity of 100%. ERCP supplemented by IDUS allowed for correct preoperative diagnosis in 83% of cases (50 of 60 patients), which was significantly higher than the accuracy of ETP (p=0.008). By combining ETP with IDUS, a correct preoperative diagnosis was made in 59 of 60 patients resulting in an accuracy rate of 98%. CONCLUSIONS: Because of its low accuracy, exclusive use of ETP is not a reliable diagnostic tool for a definitive preoperative diagnosis of bile duct strictures. By combining IDUS and ETP with ERCP however, preoperative diagnostic accuracy can be improved substantially.
Asunto(s)
Neoplasias de los Conductos Biliares/diagnóstico , Conductos Biliares/diagnóstico por imagen , Colestasis/diagnóstico , Endoscopía del Sistema Digestivo , Endosonografía , Adolescente , Adulto , Anciano , Neoplasias de los Conductos Biliares/complicaciones , Conductos Biliares/patología , Biopsia con Aguja , Colangiopancreatografia Retrógrada Endoscópica , Colestasis/etiología , Femenino , Neoplasias de la Vesícula Biliar/diagnóstico , Humanos , Masculino , Persona de Mediana Edad , Neoplasias Pancreáticas/diagnóstico , Valor Predictivo de las Pruebas , Estudios Prospectivos , Sensibilidad y EspecificidadAsunto(s)
Circulación Hepática , Fallo Hepático Agudo/cirugía , Trasplante de Hígado/métodos , Alanina Transaminasa/sangre , Fosfatasa Alcalina/sangre , Animales , Bilirrubina/sangre , Modelos Animales de Enfermedad , Trasplante de Hígado/patología , Trasplante de Hígado/fisiología , Masculino , Compuestos de Amonio Cuaternario/sangre , Ratas , Ratas Endogámicas LewRESUMEN
Intraoperative radiation techniques allow an additional local dose in areas at high-risk for local failure. With brachytherapy techniques, perioperative radiation can be fractionated. Fractionated treatment might offer an interesting alternative to a single dose, both to increase the therapeutic ratio and to protect late reacting tissues at risk. The dose distribution for brachytherapy applicators can be optimized using spacer materials. In this prospective study a new tissue equivalent bendy applicator (TEBA) that can remain in situ for several days is introduced, and the feasibility of fractionated perioperative high dose rate (HDR) brachytherapy is examined. 31 patients with different tumours (soft tissue sarcoma, Ewings sarcoma, rectal cancer, and locally infiltrating diseases) were treated. The TEBA was applied, depending on resection status and intraoperative findings. Planning was based on digitized radiographs and CT scans. Perioperative HDR brachytherapy was performed using an individual treatment schedule. In 29 patients perioperative radiation was given and in 26 cases fractionated brachytherapy application was possible. TEBA application time varied from 1 day to 11 days. During this time between 1 and 8 fractions were given with total doses from 10 Gy to 25 Gy. Fractionated perioperative brachytherapy with this technique is feasible and adequate. Further studies will show whether fractionated perioperative treatment using the TEBA technique fulfils its theoretical advantages over single dose intraoperative radiotherapy by decreased late toxicity and increased local tumour control.
Asunto(s)
Braquiterapia/instrumentación , Fraccionamiento de la Dosis de Radiación , Neoplasias/radioterapia , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Braquiterapia/efectos adversos , Braquiterapia/métodos , Niño , Preescolar , Estudios de Factibilidad , Femenino , Humanos , Lactante , Masculino , Persona de Mediana Edad , Neoplasias/diagnóstico por imagen , Dosificación Radioterapéutica , Radioterapia Adyuvante , Tomografía Computarizada por Rayos XRESUMEN
BACKGROUND AND AIMS: Liver regeneration and functional interaction between native liver and graft after auxiliary partial orthotopic liver transplantation (APOLT) are not entirely understood and, therefore, require an experimental model simulating the clinical features of acute liver failure (ALF) and the surgical technique of APOLT. MATERIALS AND METHODS: ALF was induced by subtotal hepatectomy in 50 Lewis rats (200-250 g). Sham operation (I), ALF without treatment (II), ALF with portocaval shunt for decreasing blood flow of the remnant liver (III), and ALF treated by APOLT (IV) were performed. The auxiliary graft represented a left donor liver lobe which was orthotopically implanted using a microsurgical technique including reconstruction of the graft artery and internal biliary drainage. Operative outcomes, serum chemistry and histopathological findings were examined up to the 14th day. RESULTS: ALF without treatment (groups II and III) led to a small droplet fatty degeneration in the hepatocytes and a significant increase of liver parameters until the death of the animals within the first two postoperative days ( P<0.05). After APOLT (group IV), 80% of the animals survived up to the 14th day, revealing significantly decreased liver parameters ( P<0.05), a well-perfused graft and an up to five times increased native liver size with normal architecture. CONCLUSION: This new rat model simulates the clinical features of an ALF treated by APOLT and is especially interesting for further basic research on the interaction between native liver and auxiliary graft after APOLT.
Asunto(s)
Fallo Hepático Agudo/fisiopatología , Fallo Hepático Agudo/cirugía , Regeneración Hepática/fisiología , Trasplante de Hígado/métodos , Animales , Modelos Animales de Enfermedad , Hepatectomía , Hígado/patología , Hígado/fisiopatología , Hígado/cirugía , Fallo Hepático Agudo/patología , Microcirugia/métodos , Ratas , Ratas Endogámicas Lew , Procedimientos de Cirugía Plástica/métodosRESUMEN
MARS (Molecular Adsorbent Recycling System) as a novel hepatic detoxification procedure until orthotopic liver transplantation. We report the case of a 30-year-old man who was admitted because of acute liver failure due to longstanding ethanol abuse. On conservative treatment liver function progressively deteriorated and the patient was listed for orthotopic liver transplantation. Because of a rapidly progressive and clinically severe hepatic encephalopathy together with increasing bilirubin levels (maximum 39 mg/dl) we began intermittent extracorporeal detoxification with the Molecular Adsorbent Recycling System (MARS). Under MARS therapy serum bilirubin decreased significantly (to 20 mg/dl after three cycles) and encephalopathy improved rapidly until the patient was completely oriented. No effect of MARS on liver function could be demonstrated. MARS treatment was successfully continued until a cadaver liver became available after 48 days and the patient was transplanted in good clinical and neurological condition and without complications. MARS represents a novel detoxification technique which, in patients with acute liver failure, can successfully replace hepatic detoxification until orthotopic liver transplantation can be performed.